NFKB1 and gastric cancer: The NF‐κB signalling pathway has been widely demonstrated as one of the most commonly activated and essential pathways for EMT and GC metastasis.5, 6, 7 The core of this pathway, transcription factor NF‐κB, consisting of two distinct subunits, p50 and p65, is subject to multiple levels of control.